๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Iron deficiency (ID) affects about 25% of the global population, presenting...
Status
Completed
Location
Cheng Hsin General Hospital
Start Date
2023-05-01
Trial ID
NCT06703411
Treatments Being Tested
The main objective of this study is to demonstrate the efficacy and safety ...
Status
Completed
Location
Luitpold Pharmaceuticals, Inc.
Start Date
2009-09
Trial ID
NCT00982007
The Objective of this study is to study the safety of FCM in patients with ...
Status
Completed
Location
Luitpold Pharmaceuticals
Start Date
2007-10
Trial ID
NCT00548691
Treatments Being Tested
Patients with congestive heart failure, grade 3-4, in addition to the stand...
Status
Withdrawn
Location
Department of internal medicine A
Start Date
2016-12-14
Trial ID
NCT03042130
Treatments Being Tested
Primary Hypothesis * The 24-hour post-transfusion RBC recovery of units ob...
Status
Completed
Location
Columbia University Irving Medical Center
Start Date
2017-01
Trial ID
NCT02889133
Treatments Being Tested
The purpose of this study is to find a better, more convenient way to impro...
Status
Withdrawn
Location
James Graham Brown Cancer Center
Start Date
2007-05
Trial ID
NCT00481624
Treatments Being Tested
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
Anemia is a worldwide problem with iron deficiency being the most common ca...
Status
Completed
Location
S. Nijalingappa Medical College
Start Date
2021-03-15
Trial ID
NCT05358509
Treatments Being Tested
The study design is a randomized, open-label, clinical trial of omadacyclin...
Status
Active Not Recruiting
Location
The Lundquist Institute For Biomedical Innovation at Harbor-UCLA Medical Center
Start Date
2023-05-09
Trial ID
NCT05753215
Treatments Being Tested
Anti-CD3 monoclonal antibody (a.k.a. hOKT3gamma1 \[Ala-Ala\],teplizumab, MG...
Status
Completed
Location
The Diabetes Center at UCSF
Start Date
2005-09
Trial ID
NCT00129259
Treatments Being Tested